A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

New England Journal of Medicine

Volumn 320, Issue 8, 1989, Pages 479-484

  Fisher, Bernard ^a   Costantino, Joseph ^a   Redmond, Carol ^a   Poisson, Roger ^a   Bowman, David ^a   Couture, Jean ^a   Dimitrov, Nikolay V ^a   Wolmark, Norman ^a   Wickerham, D Lawrence ^a   Fisher, Edwin R ^a   Margolese, Richard ^a   Robidoux, Andre ^a   Shibata, Henry ^a   Terz, Jose ^a   Paterson, A H G ^a   Feldman, Merrill I ^a   Farrar, William ^a   Evans, James ^a   Lickley, H Lavina ^a   Ketner, Mary ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; AXILLARY LYMPH NODE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0024506261     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198902233200802     Document Type: Article

References (15)

1. Adjuvant chemotherapy for breast cancer. JAMA 1985; 254: 3461–3.
2. Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor–negative tumors. N Engl J Med 1989; 320: 473–8.
3. Fisher B, Carbone P, Economou SG, et al. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. N Engl J Med 1975; 292: 117–22.
4. Fisher B, Redmond C, Brown A, et al. Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 1981; 305: 1–6.
5. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665–73.
6. Fisher B, Wolmark N, Fisher ER, Deutsch M. Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations. World J Surg 1985; 9: 692–8.
7. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8: 699–712.
8. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–70.
9. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc [A] 1972; 135: 185–207.
10. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning Publications, 1982:284–8.
11. Robins J, Breslow N, Greenland S. Estimators of MantelHaenszel variance consistent in both sparse data and large-strata limiting models. Biometrics 1986; 42: 311–23.
12. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
13. Fisher ER, Fisher B, Sass R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer 1984; 54: 3002–11.
14. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer: analysis at six years of Nolvadex Adjuvant Trial Organisation. Lancet 1985; 1: 836–9.
15. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish trial: report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet 1987; 2: 171–5.